Amanda Kerr
PhD
Postdoctoral Epidemiologist
Amanda Kerr works in the Late Effects team working on systematic reviews of long term outcomes of cancer treatments.
She joined the Clinical Trial Service Unit & Epidemiological Studies Unit (CTSU) as a research assistant with the Early Breast Cancer Trialists’ Collaborative Group (EBCTCG) in 2008.
Amanda went on to complete a PhD with Sarah Darby, investigating the cardiotoxic effects of anthracycline chemotherapy, graduating in 2016.